Predisposition Biomarkers Market

Future Market Insights

Key Insight

The predisposition biomarkers market is projected to grow from USD 5.6 billion in 2025 to USD 12.4 billion by 2035, at a CAGR of 8.2%. Oncology will dominate with a 46.8% market share, while hospitals will lead the end user segment with a 57.3% share.

October 04, 2025

Anurag Sharma

275 Pages

Cite this Report

Predisposition Biomarkers Market

https://www.futuremarketinsights.com/reports/predisposition-biomarkers-market

License

Buy Now

Summary ToC Companies

Key Players

Abbott Laboratories
Agilent Technologies
Bio-Rad Laboratories
Exact Sciences Corporation
Hologic
Illumina
Myriad Genetics
PerkinElmer
QIAGEN N.V
Roche
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Predisposition Biomarkers Market

Key Players

Similar Industry Reports